Research Article

Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma

Figure 2

Expression of specific (synaptophysin and chromogranin A) and non-specific (CD56, CD117) neuroendocrine markers in DCIS and invasive carcinoma. (a) Isolated chromogranin A positive cells in high-grade DCIS (inset: isolated synaptophysin positive cells in the same case). (b) High-grade DCIS with isolated CD56 positive cells. (c) High-grade DCIS diffusely expressing CD117. (d) Luminal B carcinoma NST diffusely expressing chromogranin A. (e) The same luminal B carcinoma is negative for synaptophysin. (f) Diffuse expression of CD56 in a triple-negative carcinoma.
408459.fig.002a
(a)
408459.fig.002b
(b)
408459.fig.002c
(c)
408459.fig.002d
(d)
408459.fig.002e
(e)
408459.fig.002f
(f)